Rankings
▼
Calendar
ENGN Q1 2022 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
$0
Net Income
-$215,000
EPS (Diluted)
$-0.01
Cash Flow
Operating Cash Flow
-$796,248
Free Cash Flow
-$796,248
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$131M
Total Liabilities
$4M
Stockholders' Equity
$127M
Cash & Equivalents
$1M
← FY 2022
All Quarters
Q2 2022 →